Odyssean »

Krystal Biotech shares owned by Odyssean

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.5M 9.3k 371.67

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Krystal Biotech

FMR
BlackRock
venBio Select Advisor
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Soleus Capital Management
Capital World Investors
Vestor Capital Corp
Geode Capital Management
Redmile Group
Hood River Capital Management
T. Rowe Price Associates
Bellevue Group
Frazier Life Sciences Management

View all funds holding Krystal Biotech